Nisa Investment Advisors’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$95 Sell
40
-4,000
-99% -$13.9K ﹤0.01% 3010
2025
Q4
$20.9K Hold
4,040
﹤0.01% 1925
2025
Q3
$17K Hold
4,040
﹤0.01% 2065
2025
Q2
$14.8K Sell
4,040
-224
-5% -$835 ﹤0.01% 2080
2025
Q1
$18.4K Buy
4,264
+106
+3% +$428 ﹤0.01% 1915
2024
Q4
$13.3K Buy
4,158
+268
+7% +$899 ﹤0.01% 2060
2024
Q3
$11.1K Sell
3,890
-190
-5% -$533 ﹤0.01% 2080
2024
Q2
$11.4K Sell
4,080
-25
-0.6% -$67 ﹤0.01% 2105
2024
Q1
$11.7K Buy
4,105
+190
+5% +$646 ﹤0.01% 2012
2023
Q4
$16K Sell
3,915
-35
-0.9% -$98 ﹤0.01% 1933
2023
Q3
$12.6K Buy
3,950
+40
+1% +$127 ﹤0.01% 2130
2023
Q2
$13K Buy
3,910
+3,850
+6,417% +$11.4K ﹤0.01% 2207
2023
Q1
$0 Buy
60
+35
+140% +$86 ﹤0.01% 2650
2022
Q4
$0 Buy
+25
New +$73 ﹤0.01% 2670
2022
Q2
Sell
-1,400
Closed -$11K 2472
2022
Q1
$11K Buy
+1,400
New +$10.8K ﹤0.01% 2186

Other funds holding ORGO

Nisa Investment Advisors's ORGO Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Organogenesis Holdings (ORGO) stake by 99% in Q1 2026, selling an estimated $13.9K and leaving 40 shares worth $95. The position accounts for ﹤0.01% of the portfolio, ranked #3010.

Nisa Investment Advisors first reported a position in ORGO in Q1 2022 and has held it in 15 quarters since. The position peaked at $20.9K in Q4 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Nisa Investment Advisors held 40 shares of Organogenesis Holdings worth $95 as of Q1 2026.
  • Nisa Investment Advisors sold 4,000 Organogenesis Holdings shares in Q1 2026, an estimated $13.9K.
  • Organogenesis Holdings made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #3010 holding.
  • Nisa Investment Advisors first reported a position in Organogenesis Holdings in Q1 2022 and has held it in 15 quarters since.
  • Nisa Investment Advisors's Organogenesis Holdings position peaked at $20.9K in Q4 2025.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.